Mutational analysis of ICP0R, a transrepressor protein created by alternative splicing of the ICP0 gene of herpes simplex virus type 1

The immediate-early protein ICP0 (infected-cell polypeptide 0) of herpes simplex virus type 1 (HSV-1) is a promiscuous transactivator of both viral and nonviral promoters in transient expression assays. Failure to splice the second of two introns in the ICP0 gene results in the utilization of an alternate stop codon that generates a truncated form of ICP0 called ICP0R. This protein exists in low levels in HSV-1-infected cells and functions as a dominant negative repressor of ICP0-mediated transactivation in transient expression assays. To conduct a detailed structure-function analysis of ICP0R, a series of insertion and deletion mutants of this protein were generated and analyzed in transfection assays. These studies indicated that segments of ICP0R that were rich in acidic amino acid residues (amino acids 9 to 76 and 233 to 241) or glycine residues (amino acids 242 to 262) were dispensable for the dominant negative phenotype. In contrast, the RING finger domain (amino acids 116 to 156) and surprisingly the sequences carboxy terminal to it (amino acids 157 to 232) were absolutely essential for transdominant repression. Consistent with these findings, the amino acid sequences of these two regions were conserved among other alphaherpesvirus ICP0 homologs. A construct containing only amino acids 76 to 232 inhibited ICP0-mediated transactivation almost as efficiently as wild-type ICP0R and represented the minimal sequences necessary for the dominant negative phenotype. These results demonstrated that the critical functional domain shared by both ICP0R and ICP0 is much more complex than a simple RING finger motif. Western blot (immunoblot) analyses of transfected cell lysates revealed that nearly all of the mutant constructs directed the expression of stable ICP0R proteins of the predicted molecular weight. However, there was a striking inverse correlation between the ability of a mutant construct to mediate transrepression and the amount of protein that it synthesized, indicating that dominant negative inhibition is achieved through the action of very little ICP0R protein.

[1]  Peirong Yang,et al.  Analysis of the Growth and Transformation Suppressor Domains of Promyelocytic Leukemia Gene, PML(*) , 1996, The Journal of Biological Chemistry.

[2]  Gerald M. Rubin,et al.  Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death , 1995, Cell.

[3]  R. Everett,et al.  The equine herpesvirus 1 gene 63 RING finger protein partially complements Vmw110, its herpes simplex virus type 1 counterpart. , 1995, The Journal of general virology.

[4]  D. Donner,et al.  Association of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor. , 1995, The Biochemical journal.

[5]  R. Everett,et al.  Separation of sequence requirements for HSV-1 Vmw110 multimerisation and interaction with a 135-kDa cellular protein. , 1995, Virology.

[6]  P. Freemont,et al.  The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto‐oncoprotein PML. , 1995, The EMBO journal.

[7]  R. Everett,et al.  The cellular RING finger protein PML is not a functional counterpart of the herpes simplex virus type 1 RING finger protein Vmw110. , 1995, The Journal of general virology.

[8]  G. Hayward,et al.  Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures , 1995, Journal of virology.

[9]  P. Schaffer,et al.  Physical interaction between the herpes simplex virus type 1 immediate-early regulatory proteins ICP0 and ICP4 , 1994, Journal of virology.

[10]  J. Cohen,et al.  The RING finger domain of the varicella-zoster virus open reading frame 61 protein is required for its transregulatory functions. , 1994, Virology.

[11]  R. Everett,et al.  HSV‐1 IE protein Vmw110 causes redistribution of PML. , 1994, The EMBO journal.

[12]  R. Everett,et al.  The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. , 1994, The Journal of general virology.

[13]  P. Schaffer,et al.  Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0 , 1994, Journal of virology.

[14]  R. Everett,et al.  Herpes simplex virus type 1 immediate-early protein Vmw110 binds strongly and specifically to a 135-kDa cellular protein. , 1994, Virology.

[15]  G. Hayward,et al.  Identification of a dimerization domain in the C-terminal segment of the IE110 transactivator protein from herpes simplex virus , 1994, Journal of virology.

[16]  C. Fraefel,et al.  Identification and zinc dependence of the bovine herpesvirus 1 transactivator protein BICP0 , 1994, Journal of virology.

[17]  G. Hayward,et al.  Mapping of intracellular localization domains and evidence for colocalization interactions between the IE110 and IE175 nuclear transactivator proteins of herpes simplex virus , 1994, Journal of virology.

[18]  B. Luisi,et al.  Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger. , 1994, Journal of molecular biology.

[19]  B. Luisi,et al.  A novel arrangement of zinc-binding residues and secondary structure in the C3HC4 motif of an alpha herpes virus protein family. , 1993, Journal of molecular biology.

[20]  R. Everett,et al.  A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner. , 1993, Virology.

[21]  G. Maul,et al.  Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). , 1993, The Journal of general virology.

[22]  P. Schaffer,et al.  The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency , 1993, Journal of virology.

[23]  R. Lovering,et al.  Identification and preliminary characterization of a protein motif related to the zinc finger. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. C. Weber,et al.  Antiviral properties of a dominant negative mutant of the herpes simplex virus type 1 regulatory protein ICP0. , 1992, The Journal of general virology.

[25]  E. Telford,et al.  The DNA sequence of equine herpesvirus-1. , 1992, Virology.

[26]  P. C. Weber,et al.  Identification of dominant-negative mutants of the herpes simplex virus type 1 immediate-early protein ICP0 , 1992, Journal of virology.

[27]  D. McGeoch,et al.  Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. , 1991, The Journal of general virology.

[28]  R. Everett,et al.  High level expression and purification of herpes simplex virus type 1 immediate early polypeptide Vmw110. , 1991, Nucleic acids research.

[29]  R. Everett,et al.  A herpes simplex virus type 1 mutant lacking the ICP0 introns reactivates with normal efficiency , 1991, Journal of virology.

[30]  A. Cheung,et al.  Cloning of the latency gene and the early protein 0 gene of pseudorabies virus , 1991, Journal of virology.

[31]  R. Everett Construction and characterization of herpes simplex type 1 viruses without introns in immediate early gene 1. , 1991, The Journal of general virology.

[32]  J. Trowsdale,et al.  A novel gysteine-rich sequence motif , 1991, Cell.

[33]  S. Silverstein,et al.  Mutational analysis of the sequence encoding ICP0 from herpes simplex virus type 1. , 1991, Virology.

[34]  S. Silverstein,et al.  Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products , 1990, Journal of virology.

[35]  P. Schaffer,et al.  Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA , 1989, Journal of virology.

[36]  M. Ptashne,et al.  A vector for expressing GAL4(1-147) fusions in mammalian cells. , 1989, Nucleic acids research.

[37]  N. Stow,et al.  A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice. , 1989, The Journal of general virology.

[38]  R. Everett,et al.  Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system , 1989, Journal of virology.

[39]  K. Tyler,et al.  Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency , 1989, Journal of virology.

[40]  R. Sekulovich,et al.  The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0 , 1988, Journal of virology.

[41]  R. Everett Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110. , 1988, Journal of molecular biology.

[42]  S. McKnight,et al.  Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. , 1988, Genes & development.

[43]  H. Gendelman,et al.  Activation of the human immunodeficiency virus by herpes simplex virus type 1 , 1987, Journal of virology.

[44]  J. Sodroski,et al.  Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Everett A detailed mutational analysis of Vmw110, a trans‐acting transcriptional activator encoded by herpes simplex virus type 1. , 1987, The EMBO journal.

[46]  F. Homa,et al.  Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes. , 1987, Nucleic acids research.

[47]  Jun Ma,et al.  Deletion analysis of GAL4 defines two transcriptional activating segments , 1987, Cell.

[48]  P. Schaffer,et al.  Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture , 1987, Journal of virology.

[49]  N. Stow,et al.  Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. , 1986, The Journal of general virology.

[50]  D. McGeoch,et al.  Characterization of the IE110 gene of herpes simplex virus type 1. , 1986, The Journal of general virology.

[51]  K. Struhl,et al.  Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of Yeast , 1986, Cell.

[52]  A J Davison,et al.  The complete DNA sequence of varicella-zoster virus. , 1986, The Journal of general virology.

[53]  I. Gelman,et al.  Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Knipe,et al.  Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. , 1985, Molecular and cellular biology.

[55]  G. Hayward,et al.  Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters , 1985, Journal of virology.

[56]  R. Everett Trans activation of transcription by herpes virus products: requirement for two HSV‐1 immediate‐early polypeptides for maximum activity. , 1984, The EMBO journal.